Plant ID: NPO12633
Plant Latin Name: Rapanea neurophylla
Taxonomy Genus: Rapanea
Taxonomy Family: Primulaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
TDP1; FAAH; TERT; ALOX12; ALOX15; USP2; POLB; | |
GAA; | |
MAPK1; | |
PPARA; PPARD; PPARG; | |
ALOX5; | |
KAT2B; | |
XIAP; | |
MPEG1; FABP5; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Bromodomain | KAT2B | Histone acetyltransferase PCAF | Q92831 | CHEMBL5500 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | FAAH | Anandamide amidohydrolase | O00519 | CHEMBL2243 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
Enzyme_unclassified | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | CHEMBL1293227 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Oxidoreductase | ALOX5 | Arachidonate 5-lipoxygenase | P09917 | CHEMBL215 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Transferase | XIAP | Inhibitor of apoptosis protein 3 | P98170 | CHEMBL4198 |
Unclassified | MPEG1 | Macrophage-expressed gene 1 protein | Q2M385 | CHEMBL3414409 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019372; lipoxygenase pathway | 3.148E-07 | 1.714E-03 | ALOX12, ALOX15, ALOX5 |
BP | GO:0008152; metabolic process | GO:2001303; lipoxin A4 biosynthetic process | 7.290E-07 | 1.764E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0047977; hepoxilin-epoxide hydrolase activity | 7.290E-07 | 1.764E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0004052; arachidonate 12-lipoxygenase activity | 2.186E-06 | 2.975E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0051120; hepoxilin A3 synthase activity | 2.186E-06 | 2.975E-03 | ALOX12, ALOX15 |
BP | GO:0008152; metabolic process | GO:0006691; leukotriene metabolic process | 2.507E-06 | 3.211E-03 | ALOX12, ALOX15, ALOX5 |
BP | GO:0008152; metabolic process | GO:0051122; hepoxilin biosynthetic process | 7.279E-06 | 5.716E-03 | ALOX12, ALOX15 |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 7.279E-06 | 5.716E-03 | PPARA, PPARG |
MF | GO:0005488; binding | GO:0008134; transcription factor binding | 7.350E-06 | 5.716E-03 | KAT2B, MAPK1, PPARA, PPARD, PPARG, TERT |
CC | GO:0043226; organelle | GO:0005654; nucleoplasm | 6.591E-06 | 5.716E-03 | ALOX5, FABP5, KAT2B, MAPK1, POLB, PPARA, PPARD, PPARG, TERT, USP2, XIAP |
BP | GO:0008152; metabolic process | GO:0006367; transcription initiation from RNA polymerase II promoter | 9.921E-06 | 6.516E-03 | KAT2B, PPARA, PPARD, PPARG |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 1.017E-05 | 6.516E-03 | PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 1.091E-05 | 6.601E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 1.091E-05 | 6.601E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 1.366E-05 | 8.039E-03 | ALOX12, ALOX15, FAAH |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 2.984E-07 | 3.283E-05 | FABP5, PPARG, PPARA, PPARD |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 2.097E-06 | 1.153E-04 | ALOX5, ALOX15, MAPK1, ALOX12 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.870E-05 | 6.858E-04 | ALOX5, ALOX15, ALOX12 |
09160 Human Diseases | 09167 Infectious diseases | hsa05166 | HTLV-I infection | 5.641E-05 | 1.551E-03 | POLB, KAT2B, TERT, XIAP |
09160 Human Diseases | 09167 Infectious diseases | hsa05145 | Toxoplasmosis | 1.282E-04 | 2.820E-03 | ALOX5, XIAP, MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 2.965E-04 | 4.659E-03 | XIAP, MAPK1, PPARG, PPARD |
09160 Human Diseases | 09161 Cancers | hsa05203 | Viral carcinogenesis | 6.490E-04 | 8.924E-03 | POLB, KAT2B, MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 2.724E-04 | 4.659E-03 | MAPK1, PPARG |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 1.056E-03 | 1.291E-02 | MAPK1, PPARD |
09150 Organismal Systems | 09156 Nervous system | hsa04723 | Retrograde endocannabinoid signaling | 3.268E-03 | 3.595E-02 | FAAH, MAPK1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Thrombosis | I80-I82 | ALOX5; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Allergy | T78.4 | ALOX5; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | ALOX5; |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | ALOX5; |
A00-B99: Certain infectious and parasitic diseases | Lymphatic filariasis | B74 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Dermatitis | L20-L30 | ALOX5; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | ALOX5; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | ALOX5; |
J00-J99: Diseases of the respiratory system | Respiratory disease | J00-J99 | ALOX5; |
J00-J99: Diseases of the respiratory system | Chronic obstructive pulmonary disease | J40-J44, J47 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Pruritus | L29 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | ALOX5; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | ALOX5; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | ALOX5; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Arthritis | M00-M25 | ALOX5; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | ALOX5; |
L00-L99: Diseases of the skin and subcutaneous tissue | Atopic dermatitis | L00-L99 | ALOX5; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; |
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; |
J00-J99: Diseases of the respiratory system | Rhinitis | J00, J30, J31.0 | ALOX5; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |